Prevalence and determinants of white coat effect in a large UK hypertension clinic population

Journal of Human Hypertension

Volumn 30, Issue 6, 2016, Pages 386-391

  Thomas, O ^a   Shipman, K E ^a   Day, K ^a   Thomas, M ^a   Martin, U ^b   Dasgupta, I ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AFRICAN CARIBBEAN; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CAUCASIAN; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ETHNICITY; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; PREVALENCE; PROSPECTIVE STUDY; SMOKING; SOUTH ASIAN; SYSTOLIC BLOOD PRESSURE; TUNICA ALBUGINEA; WHITE COAT HYPERTENSION; AGED; ANCESTRY GROUP; BLOOD PRESSURE; DRUG EFFECTS; ENGLAND; EPIDEMIOLOGY; ETHNOLOGY; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; TEACHING HOSPITAL; TIME FACTOR;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CONTINENTAL POPULATION GROUPS; ENGLAND; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WHITE COAT HYPERTENSION;

EID: 84941702489     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2015.95     Document Type: Article

References (35)

1. Ayman D, Goldshine AD. Blood pressure determination by patients with essential hypertension I. The difference between clinic and home readings before treatment. Am J Med Sci 1940; 200: 465-474.
2. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354: 2368-2374.
3. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102: 1139-1144.
4. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M et al. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension 2012; 59: 564-571.
5. Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M et al. The clinical significance of white-coat and masked hypertension. Blood Press Monit 2007; 12: 387-389.
6. National Institute for Health and Clinical Excellence. Hypertension: Clinical Management of Primary Hypertension in Adults. NICE Clinical Guideline 127. National Institute for Health and Clinical Excellence: London, 2011.
7. Fukuhara M, Arima H, Ninomiya T, Hata J, Hirakawa Y, Doi Y et al. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: The Hisayama study. Stroke 2013; 44: 1512-1517.
8. O'Brien E, Beevers G, Lip GY. ABC of hypertension. Blood pressure measurement. Part III-automated sphygmomanometry: ambulatory blood pressure measurement. BMJ 2001; 322: 1110-1114.
9. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA et al. Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ 2010; 340: c1104.
10. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005; 18: 1422-1428.
11. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-1137.
12. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens 2002; 20: 2183-2189.
13. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107: 1401-1406.
14. Mancia G, Omboni S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995; 8: 311-315.
15. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JP et al. British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139-185.
16. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13(12 Pt 1): 1377-1390.
17. Lindbaek M, Sandvik E, Liodden K, Mjell J, Ravnsborg-Gjertsen K. Predictors for the white coat effect in general practice patients with suspected and treated hypertension. Br J Gen Pract 2003; 53: 790-793.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
19. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. National Kidney Foundation (NKF). Part 4. Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 2002; 39(Suppl 1): S46-S75.
20. Schettini C, Bianchi M, Nieto F, Sandoya E, Senra H. Ambulatory blood pressure: normality and comparison with other measurements. Hypertension 1999; 34: 818-825.
21. Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. Evaluation of the extent and duration of the 'ABPM effect' in hypertensive patients. J Am Coll Cardiol 2002; 40: 710-717.
22. Polónia JJ, Gama GM, Silva JA, Amaral C, Martins LR, Bertoquini SE. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives. Blood Press Monit 2005; 10: 57-64.
23. MacDonald MB, Laing GP, Wilson MP, Wilson TW. White coat hypertension in treated hypertensives: a three year follow-up study. Can J Cardiovasc Nurs 2003; 13: 24-29.
24. Streitel KL, Graham JE, Pickering TG, Gerin W. Explaining gender differences in the white coat effect. Blood Press Monit 2011; 16: 1-6.
25. Sabater-Hernández D, Sánchez-Villegas P, García-Corpas JP, Amariles P, Sendra-Lillo J, Faus MJ. Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study. Int J Clin Pharm 2011; 33: 582-589.
26. Gualdiero P, Niebauer J, Addison C, Clark SJ, Coats AJ. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring. Blood Press Monit 2000; 5: 53-57.
27. Martin U, Haque MS, Wood S, Greenfield SM, Gill PS, Mant J et al. Ethnicity and differences between clinic and ambulatory blood pressure measurements. Am J Hypertens 2014; 28: 729-738.
28. Minor DS, Wofford MR, Jones DW. Racial and ethnic differences in hypertension. Curr Atheroscler Rep 2008; 10: 121-127.
29. Grassi G, Turri C, Vailati S, Dell'Oro R, Mancia G. Muscle and skin sympathetic nerve traffic during the 'white-coat' effect. Circulation 1999; 100: 222-225.
30. Manios ED, Koroboki EA, Tsivgoulis GK, Spengos KM, Spiliopoulou IK, Brodie FG et al. Factors influencing white-coat effect. Am J Hypertens 2008; 21: 153-158.
31. Kozlowski LT, Herman CP. The interaction of psychosocial and biological determinants of tobacco use: more on the boundary model. J Applied Soc Psych 1984; 14: 244-256.
32. Conen D, Aeschbacher S, Thijs L, Li Y, Boggia J, Asayama K et al. Age specific differences between conventional and ambulatory daytime blood pressure values. Hypertension 2014; 64: 1073-1079.
33. Banegas JR, Ruilope LM, De la Sierra A, De la Cruz JJ, Gorostidi M, Segura J et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J 2014; 35: 3304-3312.
34. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464-1470.
35. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Press 1995; 4: 148-156.